Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2017

Penas-Prado Marta

Abstract excerpt

The most relevant practice-changing presentations at the 2016 Society for Neuro-Oncology (SNO) Annual Scientific Meeting revolved around the topic of the new 2016 World Health Organization (WHO) classification of central nervous system (CNS) tumors. The most notable change in this new classification is the introduction of molecular markers into the morphologic classification of diffuse gliomas (isocitrate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Central Nervous System Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Transcription Factor RelA

Share to Wnt Proteins

Share to World Health Organization

Source

Identifiers

PMID: 28561706
DOI: 10.1200/EDBK_175563

Genes

RELA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.PMID 28561706Read ↗

Neuro-oncology Treatment Strategies for Primary Glial Tumors.Semantic proximity Read ↗

Management of glioblastoma: State of the art and future directions.Semantic proximity Read ↗

Congress of Neurological Surgeons Systematic Review and Evidence-based Guidelines Update on the Role of Neuropathology in the Management of Progressive Glioblastoma in AdultsSemantic proximity Read ↗

A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.Semantic proximity Read ↗

Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period.Semantic proximity Read ↗

NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.Semantic proximity Read ↗

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of RevisionSemantic proximity Read ↗

Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults.Semantic proximity Read ↗

Advances in translational research in neuro-oncology.Semantic proximity Read ↗

Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology.Semantic proximity Read ↗

Treatment of Glioblastoma.Semantic proximity Read ↗

Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.